Dendreon to restructure after drop in cancer drug sales
(Reuters) - Biotechnology company Dendreon Corp said it would restructure to cut costs after reporting another quarter of weak sales of its prostate c...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/rAhu7X8HTSg/story01.htm
No comments:
Post a Comment